Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1999
10/14/1999WO1999022773A3 Sequences for targeting metastatic cells
10/14/1999WO1999019488A8 Novel human egf receptors and use thereof
10/14/1999DE19816129A1 T-Zellrezeptor-Expressionskassette T-cell receptor expression cassette
10/14/1999DE19815331A1 Transkriptionsfaktoren und deren Verwendung Transcription factors and their use
10/14/1999CA2328294A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination
10/14/1999CA2328181A1 Immunomodulatory compositions of mmtv antigens and methods of using same
10/14/1999CA2328079A1 Method to detect biologically active, allergen-specific immunoglobulins
10/14/1999CA2327814A1 Reagents and methods for inhibiting furin protease activity
10/14/1999CA2327811A1 Short peptides for treatment of neurological degenerative diseases
10/14/1999CA2327652A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999CA2327445A1 Recombinant potyvirus construct and use thereof
10/14/1999CA2327367A1 New compounds for dna-transfection
10/14/1999CA2326598A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999CA2326388A1 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999CA2326146A1 Template associated npy y2-receptor agonists
10/14/1999CA2326066A1 A interleukin-1 receptor antagonist and uses thereof
10/14/1999CA2325571A1 Promoter and constructions for expression of recombinant proteins in filamentous fungi
10/14/1999CA2325562A1 Lyst protein complexes and lyst interacting proteins
10/14/1999CA2325354A1 Highly active forms of interferon regulatory factor proteins
10/14/1999CA2325352A1 Control of floral induction in plants and uses therefor
10/14/1999CA2325342A1 Dual avb3 and metastasis-associated receptor ligands
10/14/1999CA2325341A1 Mutagenized il13-based chimeric molecules
10/14/1999CA2325340A1 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/14/1999CA2325334A1 G-protein fusion receptors and chimeric gabab receptors
10/14/1999CA2325050A1 A novel nitroreductase and therapeutic uses therefor
10/14/1999CA2325016A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999CA2324984A1 Secreted proteins and polynucleotides encoding them
10/14/1999CA2324983A1 Hiv-specific cytotoxic t-cell responses
10/14/1999CA2324974A1 Compositions and methods for protein secretion
10/14/1999CA2324868A1 Human oxidized ldl receptor
10/14/1999CA2324656A1 Protein variant of the net1 locus
10/14/1999CA2324510A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999CA2324381A1 An integrin heterodimer and a subunit thereof
10/14/1999CA2324378A1 Glaucoma therapeutics and diagnostics
10/14/1999CA2324284A1 Peptides causing formation of compact structures
10/14/1999CA2324205A1 Circularly permuted biotin binding proteins
10/14/1999CA2228822A1 A polypeptide vector for the delivery of immunogenic epitopes to the immune system using an injection, orally, by a nasal spray, skin patch or transplantable instruments
10/13/1999EP0949335A1 Process for preparing purified dimer of bone-derived factor
10/13/1999EP0949334A1 Novel serine protease
10/13/1999EP0949333A1 Mutant measles virus antigens and genes encoding the same
10/13/1999EP0949332A2 HSSCRG1 polypeptides
10/13/1999EP0949271A1 Novel dna, novel protein, and novel antibody
10/13/1999EP0949270A1 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
10/13/1999EP0949269A1 Biosensor protein
10/13/1999EP0948652A1 Insect sodium channels from insecticide-susceptible and insecticide-resistant house flies
10/13/1999EP0948637A1 Live recombinant avian vaccine, using the infectious laryngotracheitis avian virus as vector
10/13/1999EP0948635A2 Human and mammalian dna replication origin consensus sequences
10/13/1999EP0948626A2 Synthetic bacillus thuringiensis gene encoding crylca (crylc) toxin
10/13/1999EP0948625A2 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS)
10/13/1999EP0948624A2 Mutants of streptococcal toxin a and methods of use
10/13/1999EP0948623A2 Isolated mammalian monocyte cell genes; related reagents
10/13/1999EP0948622A1 Human mage-like protein
10/13/1999EP0948621A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
10/13/1999EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999EP0948618A1 HUMAN POLYHOMEOTIC 2($i(hph2)) ACTS AS AN ONCOGENE
10/13/1999EP0948617A1 A NOVEL CLONED GABA-RECEPTOR SUBUNIT cDNA SEQUENCE AND STABLY CO-TRANSFECTED CELL LINES
10/13/1999EP0948614A2 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
10/13/1999EP0948612A2 Beta-amyloid toxicity
10/13/1999EP0948602A1 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use
10/13/1999EP0948600A2 Nanoscale particles synthesized within an assembled virion
10/13/1999EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
10/13/1999EP0948595A1 MUTANT $i(OB) RECEPTORS AND NUCLEOTIDES ENCODING THEM
10/13/1999EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999EP0948543A1 Hvem polypeptides and uses thereof
10/13/1999EP0948542A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/13/1999EP0948541A2 Analogs of parathyroid hormone
10/13/1999EP0948540A2 Method for solubilization and naturation of somatotropins
10/13/1999EP0948539A2 Peptides and compounds that bind to a receptor
10/13/1999EP0948538A1 Analysis and separation of platelet-derived growth factor proteins
10/13/1999EP0948537A2 Protein binding fragments of gravin
10/13/1999EP0948536A1 A g protein-coupled receptor with an enlarged extracellular domain
10/13/1999EP0948535A1 Novel lanthionine antibiotic compositions and methods
10/13/1999EP0948534A1 Meningococcus vaccine comprising the valence of bz83 strain
10/13/1999EP0948533A1 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES
10/13/1999EP0948532A1 Mouse galanin receptor galr2 and nucleotides encoding same
10/13/1999EP0948531A1 Secreted human proteins
10/13/1999EP0948530A2 Mammalian cell surface antigens; related reagents
10/13/1999EP0948529A1 Human galanin receptor galr2 and nucleotides encoding same
10/13/1999EP0948528A2 $i(STREPTOCOCCUS UBERIS) LACTOFERRIN-BINDING PROTEIN
10/13/1999EP0948526A1 Contryphan peptides
10/13/1999EP0948522A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
10/13/1999EP0948520A1 Tissue specific expression of retinoblastoma protein
10/13/1999EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/13/1999EP0948517A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF
10/13/1999EP0948516A1 Method for determining expression of aberrant forms of apc protein
10/13/1999EP0948515A1 Human b-cell translocation genes-2 and 3
10/13/1999EP0948511A2 Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0948508A1 Novel coding sequences from herpes simplex virus type-2
10/13/1999EP0948360A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use
10/13/1999EP0948354A1 Calcium-independent modulation by cd81 of receptor signalling
10/13/1999EP0948351A1 Synthetic hpv16 virus-like particles
10/13/1999EP0948348A1 Manipulation of non-terminally differentiated cells using the notch pathway
10/13/1999EP0948347A1 Antiviral and antitumor agents
10/13/1999EP0948343A1 Alkyl peptide amides and applications
10/13/1999EP0948340A1 Biologically active substances, method for obtaining and compositions containing them
10/13/1999EP0948337A1 Treatment of hemoglobin containing erythrocytes with nitric oxide
10/13/1999EP0948323A1 Protease-activated receptor 3 and uses thereof
10/13/1999EP0828503A4 Treatment for inhibiting the progression of autoimmune disease
1 ... 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 ... 2916